| Immunomodulatory cytokines as therapeutic agents for melanoma. | |
| | |
MedLine Citation:
|
PMID: 21554095 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Melanoma is the most aggressive form of skin cancer whose worldwide incidence is rising faster than any other cancer. Few treatment options are available to patients with metastatic disease, and standard chemotherapeutic agents are generally ineffective. Cytokines such as IFN-α or IL-2 can promote immune recognition of melanoma, occasionally inducing dramatic and durable clinical responses. Here, we discuss several immunomodulatory agents, the safety of which are being evaluated in clinical trials. Challenges include an incomplete understanding of signaling pathways, appropriate clinical dose and route, and systemic immunosuppression in advanced melanoma patients. We consider how targeted cytokine therapy will integrate into the clinical arena, as well as the low likelihood of success of single cytokine therapies. Evidence supports a synergy between cytokine immunotherapy and other therapeutic approaches in melanoma, and strengthening this area of research will improve our understanding of how to use cytokine therapy better. |
| | |
Authors:
|
Courtney Nicholas; Gregory B Lesinski |
Related Documents
:
|
18611985 - Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that res... 20226805 - Arsenic alters monocyte superoxide anion and nitric oxide production in environmentally... 11987985 - Aberrant expression of the costimulatory molecule cd40 ligand on monocytes from patient... 8329565 - Dexamethasone enhances agonist induction of tissue factor in monocytes but not in endot... 22058415 - Uric acid-driven th17 differentiation requires inflammasome-derived il-1 and il-18. 15710175 - Inorganic arsenite alters macrophage generation from human peripheral blood monocytes. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Immunotherapy Volume: 3 ISSN: 1750-7448 ISO Abbreviation: Immunotherapy Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-05-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101485158 Medline TA: Immunotherapy Country: England |
Other Details:
|
Languages: eng Pagination: 673-90 Citation Subset: IM |
Affiliation:
|
The Ohio State University, Department of Internal Medicine, Division of Medical Oncology, Columbus, OH 43210, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Re-inventing intratumoral immunotherapy for melanoma.
Next Document: Chronic ?-adrenergic stimulation increases ErbB receptors and cell proliferation in mouse kidney.